NovaBay Pharmaceuticals, Inc. – AMEX:NBY
NovaBay Pharmaceuticals stock price today
NovaBay Pharmaceuticals stock price monthly change
NovaBay Pharmaceuticals stock price quarterly change
NovaBay Pharmaceuticals stock price yearly change
NovaBay Pharmaceuticals key metrics
Market Cap | 2.44M |
Enterprise value | N/A |
P/E | -0.17 |
EV/Sales | -0.11 |
EV/EBITDA | 0.14 |
Price/Sales | 0.04 |
Price/Book | 0.09 |
PEG ratio | N/A |
EPS | -2.14 |
Revenue | 14.22M |
EBITDA | -4.98M |
Income | -13.11M |
Revenue Q/Q | -15.78% |
Revenue Y/Y | 4.28% |
Profit margin | -64.12% |
Oper. margin | -94.39% |
Gross margin | 54.02% |
EBIT margin | -94.39% |
EBITDA margin | -35.03% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeNovaBay Pharmaceuticals stock price history
NovaBay Pharmaceuticals stock forecast
NovaBay Pharmaceuticals financial statements
| Jun 2023 | 4.61M | -4.03M | -87.46% |
|---|---|---|---|
| Sep 2023 | 3.25M | -1.75M | -53.98% |
| Dec 2023 | 3.72M | -4.10M | -110.22% |
| Mar 2024 | 2.63M | -3.21M | -122.16% |
| Sep 2025 | 4.85M | 112.3K | 2.32% |
|---|---|---|---|
| Oct 2025 | 5M | 4.31M | 86.35% |
| Dec 2025 | 6.17M | 140.76K | 2.28% |
| Dec 2025 | 5.45M | 17.27M | 316.89% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 16008000 | 7.44M | 46.51% |
|---|---|---|---|
| Sep 2023 | 12852000 | 5.81M | 45.25% |
| Dec 2023 | 9034000 | 5.72M | 63.32% |
| Mar 2024 | 5357000 | 5.19M | 97.01% |
| Jun 2023 | -1.84M | -2K | 2.51M |
|---|---|---|---|
| Sep 2023 | -363K | -2K | -577K |
| Dec 2023 | -201K | -2K | -139K |
| Mar 2024 | -1.59M | 1.06M | -578K |
NovaBay Pharmaceuticals alternative data
| Aug 2023 | 29 |
|---|---|
| Sep 2023 | 29 |
| Oct 2023 | 29 |
| Nov 2023 | 29 |
| Dec 2023 | 29 |
| Jan 2024 | 29 |
| Feb 2024 | 29 |
| Mar 2024 | 29 |
| Apr 2024 | 29 |
| May 2024 | 24 |
| Jun 2024 | 24 |
| Jul 2024 | 24 |
NovaBay Pharmaceuticals other data
| Period | Buy | Sel |
|---|---|---|
| Sep 2022 | 10000 | 582736 |
| Nov 2022 | 0 | 23840 |
| Dec 2022 | 0 | 2 |
| Quarter | Transcript |
|---|---|
| Q1 2024 9 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 26 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 9 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 12 Aug 2023 | Q2 2023 Earnings Call Transcript |
-
What's the price of NovaBay Pharmaceuticals stock today?
One share of NovaBay Pharmaceuticals stock can currently be purchased for approximately $0.96.
-
When is NovaBay Pharmaceuticals's next earnings date?
Unfortunately, NovaBay Pharmaceuticals's (NBY) next earnings date is currently unknown.
-
Does NovaBay Pharmaceuticals pay dividends?
No, NovaBay Pharmaceuticals does not pay dividends.
-
How much money does NovaBay Pharmaceuticals make?
NovaBay Pharmaceuticals has a market capitalization of 2.44M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.24% to 14.73M US dollars.
-
What is NovaBay Pharmaceuticals's stock symbol?
NovaBay Pharmaceuticals, Inc. is traded on the AMEX under the ticker symbol "NBY".
-
What is NovaBay Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of NovaBay Pharmaceuticals?
Shares of NovaBay Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are NovaBay Pharmaceuticals's key executives?
NovaBay Pharmaceuticals's management team includes the following people:
- Mr. Justin M. Hall Esq. Pres, Chief Executive Officer, Gen. Counsel, Chief Compliance Officer, Corporation Sec. & Director(age: 47, pay: $400,720)
- Mr. Andrew D. Jones Chief Financial Officer & Treasurer(age: 54, pay: $238,220)
-
How many employees does NovaBay Pharmaceuticals have?
As Jul 2024, NovaBay Pharmaceuticals employs 24 workers, which is 17% less then previous quarter.
-
When NovaBay Pharmaceuticals went public?
NovaBay Pharmaceuticals, Inc. is publicly traded company for more then 17 years since IPO on 26 Oct 2007.
-
What is NovaBay Pharmaceuticals's official website?
The official website for NovaBay Pharmaceuticals is novabay.com.
-
Where are NovaBay Pharmaceuticals's headquarters?
NovaBay Pharmaceuticals is headquartered at 2000 Powell Street, EmeryVille, CA.
-
How can i contact NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals's mailing address is 2000 Powell Street, EmeryVille, CA and company can be reached via phone at +51 08998800.
NovaBay Pharmaceuticals company profile:
NovaBay Pharmaceuticals, Inc.
novabay.comAMEX
24
Biotechnology
Healthcare
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and PhaseOne brands. The company also provides dermatological solutions to address skincare concerns comprising keratosis pilaris, rosacea and eczema, anti-aging, SPF, hyperhidrosis, excessive hair, and acne under the DERMAdoctor brand. It sells its products through retailers, digital beauty channels, and distributors, as well as online. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California.
EmeryVille, CA 94608
CIK: 0001389545
ISIN: US66987P3001
CUSIP: 66987P201
